Health Condition 1: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: Nebulisation in acute bronchial asthma
Intervention -Group B nebulised with magnesium sulphate and levosalbutamol
Comparator agent-Group A nebulised with levosalbutamol.
: Group B is ne
Sponsors
Shyam Shah medical college
Eligibility
Inclusion criteria
Inclusion criteria: Patients newly diagnosed or known cases of bronchial asthma,aged 2-15 years are Nebulized bronchodilator which will be levosalbutamol in group (A) in the form of 4 doses of nebulized solution 0.5 gm% (each dose 1 ml containing 5 mg levosalbutamol) twenty minutes apart and magnesium sulphate in group (B) in the form of 2 doses of nebulized solution 10 gm% (each dose 1 ml containing 100 mg magnesium sulphate) twenty minutes apart with 4 doses of nebulized solution 0.5 gm percent (each dose 1ml containing 5 mg levosalbutamol) twenty minutes apart Reassessment of the patients will be performed after 2 hours to detect improvement.
Exclusion criteria
Exclusion criteria: 1.Fever 2.Smoker 3.COPD patients 4.Pneumonia 5.Cardiac,renal or hepatic insufficiency 6.Respiratory failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reassessment of vitals heart rate,respiratory rate,saturation,Glass Gow Coma scale and peak expiratory flow metre at baseline and after 2 hours.Timepoint: Reassessment of vitals heart rate,respiratory rate,saturation,Glass Gow Coma scale and peak expiratory flow metre at baseline and after 2 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of stay in intensive care unit. Duration of hospital stayTimepoint: Duration of stay in intensive care unit Duration of hospital stay | — |
Countries
India
Contacts
Public ContactDr Shabd Singh Yadav
Shyam Shah medical college
Outcome results
None listed